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Background: The effect of paternal age on semen quality is controversial. In this retrospective study, the aim was
to investigate the effects of advancing age on sperm parameters including reactive oxygen species (ROS), total
antioxidant capacity (TAC) and sperm DNA damage in infertile men. We also examined whether paternal age >40 y
is associated with higher risk of sperm DNA damage.
Methods: A total of 472 infertile men presenting for infertility were divided into 4 age groups: group A: patients ≤ 30 y;
group B: patients 31- 40 y, group C: ≤ 40 y and group D: patients >40 y. The following tests were performed - semen
analysis according to WHO 2010 criteria, seminal ROS by chemiluminescence, TAC by colorimetric assay and sperm DNA
damage by TUNEL assay - and the results were compared amongst the 4 age groups.
Results: There was no statistical difference in conventional semen parameters, TAC and ROS with advancing paternal
age as well as between different age groups. However, a significant negative association was noted between sperm
DNA damage and advancing paternal age. Men >40 y showed higher levels of sperm DNA damage (24.4 ± 18.5%)
compared to younger men (<30 y; 16.7 ± 11.2%; p <0.05).
Conclusions: Infertile men over the age of 40 y have a greater percentage of sperm DNA fragmentation compared to
infertile men aged 40 y and below. Advanced paternal age (>40 y) may increase the risk of sperm DNA damage in
infertile men.
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Many couples in developed countries are delaying par-
enthood for a variety of reasons [1-3]. Most believe that
delayed parenthood has many advantages [4]. In England
and Wales, 25% of live births in 1993 were to fathers
older than 35 y but after 10 years, the percentage in-
creased to 40% [5]. In the USA, birth rates for men older
than 35 y have increased 40% since 1980 [2,6].
The effect of maternal ageing on fertilization and
reproduction is well known [7]. Several studies have
shown that women over 35 y have a higher risk of infertil-
ity, pregnancy complications, spontaneous abortion, con-
genital anomalies, and perinatal complications [2,8-10].
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article, unless otherwise stated.quality is controversial for a couple of reasons. First, there
is no universal definition for advanced paternal ageing.
The mean population age for paternal age is 21 y, and 40 y
is the most frequently used cutoff to describe advanced
paternal ageing [2].
Secondly, the literature is full of studies with conflict-
ing results, especially for the most common parameters
tested (volume, concentration, motility, total sperm count,
morphology) [11-17]. A recent meta-analysis showed a
consistent impact of advanced age on semen volume but
the effect on the other semen parameters was inconsistent
[18]. Advancing paternal age has a negative impact on
semen volume [15,19,20], sperm motility [19,20], and nor-
mal morphology [19,21,22]. Sperm concentration did not
show any correlation with male age [23,24] while another
report showed an increase with age [25].
Advancing paternal age also has been associated with
increased risk of genetic disease [26,27], schizophreniatral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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eral studies show that advanced paternal age increases
the risk of spontaneous abortions [30,31], and increased
risk of low birth weight [32]. De La Rochebrochard and
Thonneau found that men who were older than 40 y
were at high risk for infertility [33]. The same group also
reported higher risk of infecundity and miscarriages in
women ≥35 y and men ≥40 y [34].
One possible explanation for the negative effects of ad-
vanced paternal age on reproductive outcome is sperm
DNA damage [21,35]. Intact sperm DNA is essential for
fertilization and for the genetic transmission to the next
generation [23,36]. Sperm DNA damage is associated
with reduced fertility [37], increased miscarriage rates
[38], abnormal embryonic development [39], and com-
promised chromosomal integrity in the embryo [40].
Even though the effect of advanced paternal age on
sperm DNA damage has been studied, the results are in-
consistent as different age groups and different measure-
ment techniques were used [23,24,41-43].
The aims of this study were to assess the effects of ad-
vancing age on sperm parameters including reactive oxy-
gen species, total antioxidant capacity and sperm DNA
damage in infertile men and investigate if a paternal age




We conducted a retrospective review of the medical re-
cords of patients who presented to our Andrology clinic
with a history of infertility of at least 1 y. The Cleveland
Clinic Institutional Review Board had approved this
study. We examined the medical records of patients at-
tending the Andrology laboratory for semen analysis be-
tween 2010 to September 2012. The purpose of this
study was to explore the overall effect of ageing in non-
azoospermic infertile men (n = 472) regardless of their
type of infertility. Patients were assigned to 4 groups
based on their age: group A: patients ≤30 y (n = 69;
14.6%), group B: patients 31-40 y (n = 298; 63.2%),
C: ≤40 y and group D: patients >40 y (n = 105; 22.2%).
All patients underwent a detailed medical history and
physical examination. Incidence and duration of primary
and secondary infertility was recorded. Primary infertility
is defined when no pregnancy is established at any point
by the couple. Secondary infertility is when a biological
pregnancy has been established once but subsequent
pregnancies cannot be established in the same couple.
Conventional semen parameters (semen volume, con-
centration, motility, and normal morphology), total anti-
oxidant capacity (TAC), seminal reactive oxygen species
(ROS), and sperm DNA damage were noted. We also col-
lected additional information regarding the presence/stageof varicocele, alcohol and cigarette use. All partners of
these men were ruled out for any female-factor infertility.
Semen samples were obtained from patients who were
identified with varicocele and had not undergone surgery
for varicocele repair.
Semen analysis
Semen samples were collected by masturbation after 3-5
days of sexual abstinence. Five μL of a liquefied sample
was loaded on a 20 micron MicroCell slide (Vitrolife,
San Diego, CA). A minimum of 200 spermatozoa were
examined in each sample. The conventional semen param-
eters such as sperm concentration, percentage motility and
normal sperm morphology were assessed according to the
2010 World Health Organization 5th edition criteria [44].
Total antioxidant capacity (TAC)
Following completion of initial semen analysis, an ali-
quot of the sample was centrifuged at 1600 rpm for 7 mi-
nutes. Clear supernatant was removed and batched and
stored at – 80°C for measurement of seminal antioxidant
concentrations. The total antioxidant capacity (TAC) of
the seminal plasma was measured using an antioxidant
assay kit (Cayman Chemical Company, Ann Arbor, MI).
Its principle is based on the ability of aqueous- and
lipid-based antioxidants in seminal plasma to inhibit oxi-
dation of the ABTS (2,2′-Azino-di-[3-ethylbenzthiazoline
sulphonate]) to ABTS•+. Frozen seminal plasma samples
and the contents of the assay kit were removed and thawed
at room temperature (25°C) for 20 minutes. Seminal
plasma vials were centrifuged at 5,000 rpm for 7 minutes.
Clear seminal plasma was removed into labeled 2 mL
eppendorf tubes. The seminal plasma was diluted with
assay buffer (1:10 vol./vol.). For the assay, 10 μL of the di-
luted seminal plasma and the standard (trolox) were run in
duplicate. 10 μL of metmyoglobin and 150 μL of chromo-
gen were added to each well. The reaction was initiated by
adding of 40 μL of hydrogen peroxide (working solution)
using a multi-channel pipette as described earlier [45]. The
antioxidants present in the seminal plasma suppress ab-
sorbance to a degree that is proportional to their concen-
tration. The measurement was read at 750 nm using
Microplate Reader (Epoch BioTek Gen 5 Absorbance; Bio-
Tek Instruments, Inc., Winooski, VT). The results were
expressed as micromolar trolox equivalents [45].
Reactive oxygen species (ROS)
Seminal ROS was measured in the liquefied seminal ejacu-
lates without any further processing with a chemilumines-
cence assay. Luminol (5 mM; 5-amino-2, 3-dihydro-1,
4-phthalazinedione; Sigma Chemical Co., St. Louis, MO)
was used as the probe. Test samples consisted of luminol
(10 μL, 5 mM) and 400 μL of liquefied seminal ejaculate.
Negative controls were prepared by replacing the sperm
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control included 400 μL of PBS and 50 μL of hydrogen
peroxide (30%; 8.8 M) in triplicate. Chemiluminescence
was measured for 15 min using a Berthold lumin-
ometer (Autolumat Plus 953; Oakridge, TN). Results were
expressed as relative light units (RLU)/sec. Sperm concen-
tration was calculated and final ROS levels were adjusted
by dividing with the sperm concentration to represent the
final levels of ROS (RLU/sX106 sperm [46].
Sperm DNA damage
Sperm DNA damage was evaluated by the terminal
deoxynucleotidyl transferase-mediated deoxyuridine bio-
tin nick-end labeling (TUNEL) assay with an Apo-Direct
kit (Pharmingen, San Diego, CA). The sperm concentra-
tion was adjusted to 5 × 106 sperm/mL. The TUNEL
assay involves multiple washing and resuspending steps
and some sperm are lost at each step. Spermatozoa were
washed in phosphate-buffered saline (PBS) and the
spermatozoa were re-suspended in ice-cold 3.7% para-
formaldehyde for 30-60 minutes. Paraformaldehyde was
removed by centrifugation and re-suspended in 70% ice-
cold ethanol. Before staining, sperm were washed twice
in ‘Wash buffer’ and re-suspended in staining solution
(50 μL for 60 minutes at 37°C) as per manufacturer’s in-
structions. After incubation, samples were washed twice
with 1 mL of ‘Rinse buffer’. 0.5 mL of propidium iodine/
RNase solution was added and samples were incubated
for 30 minutes before the flow cytometric analysis to
measure positive cells for DNA damage [47]. Both posi-
tive and negative controls were included with each run.
Positive controls consisted of spermatozoa treated with
DNase I. Negative controls were prepared by omitting
TdT from the staining solution. The results were expressed
as the percentage of sperm with DNA damage.
Spermatozoa/events obtained in the plots were gated
using a forward-angle light scatter (FSC) and a side-
angle light scatter (SSC) dot plot to gate out debris, ag-
gregates, and other cells different from spermatozoa.
TUNEL-positive spermatozoa in the population were
measured after converting the data into a histogram.
The percentage of positive cells (TUNEL-positive) were
calculated on a 1,023-channel scale using the flow cyt-
ometer software FlowJo Mac version 8.2.4 (FlowJo, LLC,
Ashland, OR) [47].
Statistical analysis
Fisher’s exact test or Chi square was used to compare
groups of qualitative variables (infertility- primary or
secondary). The Kruskal-Wallis test was used to com-
pare groups of quantitative variables (abstinence, vol-
ume, concentration, motility, and morphology, duration
of infertility, ROS, TAC and DNA damage). Data are
represented as mean ± standard deviation (SD) for allthe variables except ROS, which was represented as me-
dian (25th; 75th percentile). A P value <0.05 was consid-
ered statistically significant.
Results
The study group was composed of 472 non-azoospermic
infertile men who presented to our andrology clinic. All
patients were advised of 2-3 days of abstinence before
providing a semen sample. In this study the overall ab-
stinence time was 3.8 ± 2.0 days. It was 3.8 ± 2.8 days
in the <30 y; 3.7 ± 1.5 days in 31-40y and 4.2 ± 2.6 days
in >40 y group. The age ± standard deviation (SD) was
36.8 ± 6.7 y. The mean, median, and range of ages in the
4 groups was: ≤30 y: mean = 28.2 y, median = 29 y,
range = (22 y, 30 y); 31 - 40 y: mean = 35.3 y, median =
35 y, range = (31 y, 40 y) and >40 y: mean = 46.6 y,
median = 45 y, range = (41 y, 68 y). The overall infertility
duration of the men in our study was 1.2 ± 0.6 y; 1.1 ± 0.4 y
in ≤30 y group; 1.2 ± 0.6 y in 31-40 y group; 1.2 ± 0.5 y
in <40 y and 1.4 ± 0.7 y in >40 y group. A significant
difference was noted in the duration of infertility be-
tween <30 y vs. >40 y group (p = 0.004) and 31 - 40 y
vs. >40y (p <0.012).
375 of 471 of the patients (79.6%) presented with pri-
mary infertility while only 96 of 471 (20.4%) presented
with secondary infertility. Duration of primary infertil-
ity in our study was higher in men >40 y compared to
those ≤30 y. The overall duration of infertility (primary
and secondary) was 2.3 ± 1.9 y. In the majority of these
patients 192/460 (41.7%) the duration of infertility was
1 y, while in 150/460 (32.6%) the duration was 2 y.
Overall, 84.6% of the patients (389/460) had infertility
duration of 1-3 y. Of the patients, 77.8% (367/472)
were ≤40 y and 22.2% (105/472) were >40 y. Significant
differences were seen between the duration of infertility
and the different age groups. 92.5% (62/67) of men ≤30 y
had 1-3 y of infertility, while this number significantly de-
creased to 74.7% (74/99) in men >40 y. Inversely the dur-
ation of infertility >5 y increased from 3% in men ≤30 y
to 11.1% in men >40 y.
The overall mean ± standard deviation (SD) for various
sperm parameters in the 4 age groups is shown in
Table 1. No significant differences were seen in the con-
ventional semen parameters, TAC and ROS levels in the
4 age groups. However, a significant increase in sperm
DNA damage was seen with advancing paternal age
(Figure 1). Sperm DNA damage was statistically signifi-
cantly higher in patients >40 y compared to the younger
patients. When the patients were grouped into 2 groups
i.e. ≤40 y and >40 y, semen parameters were comparable
between the overall as well as the two groups (Table 1).
However, higher levels of DNA damage were seen in
men >40 y when compared with men ≤40 y (P < 0.05) as
well as in the overall group (P < 0.01).
Table 1 Comparison of semen parameters between overall and 4 age groups
Parameters Overall ≤30 y 31 – 40 y <40 y >40 y
(n = 69) (n = 298) (n = 367) (n = 105)
(n = 472) 69/472 (14.6%) 298/472 (63.1%) 367/472 (77.8%) 105/472 (22.2%)
Volume (mL) 3.1 ± 1.5 3.4 ± 1.5 3 ± 1.4 3.1 ± 1.4 3.1 ± 1.75
Concentration (X106/mL) 42.01 ± 50.58 36.66 ± 39.72 42.62 ± 52.23 41.50 ± 50.12 43.80 ± 52.37
Motility (%) 44.7 ± 19.7 44.3 ± 14.4 45.2 ± 19.5 45.0 ± 18.6 43.5 ± 22.9
Normal Morphology (%) 3.2 ± 2.9 3.1 ± 2.7 3.1 ± 2.9 3.1 ± 2.9 3.3 ± 3.1
TAC (micromolar trolox) 1964.42 ± 683.77 2114.02 ± 548.93 1948.80 ± 689.78 1974.03 ± 671.09 1930.87 ± 727.40
ROS (RLU/sec/X106) 267.7 (59.3; 1277.3) 311.1 (38.4; 1927.3) 256.9 (65.9; 1149.1) 265.6 (63.8; 1204.1) 429.9 (54.9; 1514.0)
Sperm DNA damage (%) 19.9 ± 15.3 16.7 ± 11.2 19.1 ± 14.6 18.7 ± 14. 1 24.4 ± 18.5a,b,c,d
The results are presented as mean ± SD for all the parameters except ROS which is presented as median (25th; 75th percentile).
aP value <0.05 when >40 y group was compared with the overall group.
bP value <0.05 when >40 y group was compared with the group ≤30 y.
cP value <0.05 when >40 y group was compared with the group 31-40 y
dP value <0.05 when >40 y group was compared with the group <40 y.
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significant differences were seen in the frequency of
smoking in men in the two age groups (≤40 y or >40 y).
66.2% of the men consumed alcohol. However the distri-
bution of alcohol use was similar in men ≤40 y or >40 y.
Varicocele was detected in 253/470 (53.8%) of men, and
the frequency was not significant (55.9% and 46.6%) in
men ≤40 y or >40 y. The incidence of grade 2 varicocele
was higher than grade 1 (49.6% vs. 39.6%) although this
was comparable between men ≤40 y (49.3%) or >40 y
(51.1%). The distribution of the semen parameters inFigure 1 DNA damage in the different age groups of infertile
men. Percentage of DNA damage assessed using the TUNEL method
is shown on the Y-axis and age group on the X-axis. Significantly
higher levels of DNA damage was seen in >40 y compared to
the ≤30 y.these groups is shown in Table 2. Among the alcohol
users, the antioxidant concentration was lower in the
31 - 40 y group compared to the ≤30 y (p <0.024).
Discussion
The effect of paternal age on semen quality is controver-
sial. To help clarify the issue, we looked at a number of
variables relating to semen quality in men older and
younger than 40 y of age. We first looked at conven-
tional semen parameters and found that they were not
associated with advancing age, which is comparable to
results of previous studies [14,18,48]. These men were
not typically ‘old’ and hence we did not see dramatic
change in the semen parameters compared to the youn-
ger group.
The lack of differences in semen parameters between
the age groups seen in our study may be attributed to
the patient enrollment. These patients are likely to have
significant spermatozoa damage. This does not rule out
the possibility that these same parameters may worsen
with age should this study be done among the general
population. Furthermore, this was a retrospective study,
however a longitudinal study examining the effect of age
on sperm parameters especially DNA damage would be
ideal especially in a non-selected population. All patients
attending our center were in the reproductive age group
interested in initiating a pregnancy. We reported the
overall percentage motility only and did not classify it
into different categories.
We next looked at paternal age and oxidative stress
levels. Oxidative stress, the state of imbalance between
production of ROS and antioxidant capacity, is known
to affect male fertility potential [49]. Although the effect
of ROS on male fertility has been extensively investi-
gated, there is lack of data on the relationship between
advanced paternal age and seminal ROS levels. Cocuzza
Table 2 Comparison of semen parameters between overall and 4 age groups among varicocele, smokers and alcohol users
Group Parameter Overall ≤30 y 31 – 40 y <40 y >40 y
(n = 472) (n = 69) (n = 298) (n = 367) (n = 105)
Varicocele (n = 253) Volume (mL) 3.1 ± 1.5 3.4 ± 1.5 3.1 ± 1.5 3.2 ± 1.5 3.1 ± 1.9
Concentration (X106/mL) 42.01 ± 50.58 33.43 ± 39.19 31.25 ± 37.10 31.67 ± 37.42 35.91 ± 44.58
Motility (%) 44.7 ± 19.7 46.3 ± 14.5 41.9 ± 19.9 42.5 ± 19.1 40.0 ± 22.1
Normal Morphology (%) 3.2 ± 2.9 3.1 ± 2.6 2.8 ± 2.8 2.9 ± 2.7 2.9 ± 2.8
TAC (micromolar trolox) 1964.42 ± 683.77 1985.10 ± 674.43 1842.23 ± 699.77 1985.10 ± 674.43 1977.51 ± 737.31
ROS (RLU/sec/X106) 267.7 (59.3; 1277.3) 1078.7 (37.7; 8611.2) 484.7 (94; 2144.3) 316.6 (90.5; 1197.7) 265.6 ± 234.8 (41; 1322.7)
Sperm DNA damage (%) 19.9 ± 15.3 18.9 ± 11.0 17.6 ± 11.1 17.7 ± 11.7 22.0 ± 15.9
Smokers (n = 100) Volume (mL) 3.1 ± 1.5 2.9 ± 1.4 3.0 ± 1.4 3.0 ± 1.4 2.6 ± 1.4
Concentration (X106/mL) 42.01 ± 50.58 30.86 ± 33.13 44.20 ± 50.23 42.14 ± 48.07 53.89 ± 77.41
Motility (%) 44.7 ± 19.7 45.2 ± 16.2 43.9 ± 17.5 44.2 ± 17.2 49.9 ± 25.5
Normal Morphology (%) 3.2 ± 2.9 3.8 ± 2.8 3.1 ± 3.0 3.2 ± 3.0 3.5 ± 2.6
TAC (micromolar trolox) 1964.42 ± 683.77 2146.67 ± 503.39 1842.23 ± 699.77 1883.75 ± 681.28 1683.08 ± 873.09
ROS (RLU/sec/X106) 267.7 (59.3; 1277.3) 1078.7 (37.7; 8611.2) 484.7 (94; 2144.3) 485 (90.6; 2238.3) 743.2 (215.8; 2744.2)
Sperm DNA damage (%) 19.9 ± 15.3 18.9 ± 11.0 17.6 ± 11.1 17.8 ± 11.0 16.0 ± 10.9
Alcohol users (n = 296) Volume (mL) 3.1 ± 1.5 3.1 ± 1.5 3.1 ± 1.5 3.1 ± 1.3 3.1 ± 1.7
Concentration (X106/mL) 42.01 ± 50.58 33.43 ± 39.19 31.25 ± 37.10 43.67 ± 51.69 41.07 ± 55.82
Motility (%) 44.7 ± 19.7 46.3 ± 14.5 41.9 ± 19.9 44.7 ± 20.2 45.3 ± 25.5
Normal Morphology (%) 3.2 ± 2.9 3.1 ± 2.6 2.8 ± 2.8 3.2 ± 2.9 3.2 ± 3.1
TAC (micromolar trolox) 1964.42 ± 683.77 2250.50 ± 513.30 1898.15 ± 672.16a 1944.48 ± 660.19 1940.45 ± 733.36
ROS (RLU/sec/X106) 267.7 (59.3; 1277.3) 390.6 (150.5; 2434.8) 244.4 (59.3; 866.8) 265.6 (66.2; 964.6) 346.9 (58.2; 1494.3)
Sperm DNA damage (%) 19.9 ± 15.3 16.6 ± 12.3 19.8 ± 16.2 17.7 ± 11.7 24.1 ± 19.1
The results are presented as mean ± SD for all the parameters except ROS which is presented as median (25th; 75th percentile).
aP value <0.05 when 31-40 y group was compared with ≤30 y group.
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men and found a correlation between advanced male
age (over 40 y) and high levels of ROS [22]. In this study,
we did not find a significant association between ad-
vanced male age and seminal ROS levels. Similarly, TAC
levels were not significantly different in males over 40 y
old compared to that of males below 40 y of age.
Sperm DNA damage was assessed in the present study
as well. It has been associated with low fertilization
rates, increased risk of abortion and increased incidence
of disease in offspring [50]. It is also considered a strong
predictor of male fertility [51]. In our study, we found an
association between advancing male age and sperm
DNA damage using the TUNEL assay. This finding is
consistent with numerous other studies that have shown
increases in sperm DNA damage with advancing paternal
age using different sperm DNA damage measurement
techniques including the sperm chromatin structure assay
(SCSA) [52,53], single-cell gel electrophoresis (COMET)
[54], and TUNEL assay [41]. Contrary to this, some studies
did not find any significance of advancing male age on
sperm DNA damage [21,23,24]. Plastira et al. showed in-
crease in sperm DNA damage with age only in infertilepatients with oligoasthenoteratozoospermia (OAT) but
there was no difference in the control group [25].
In the current study, we found that infertile men >40 y
were at higher risk of sperm DNA damage compared to
younger men. Studies which reported correlation be-
tween male age and sperm DNA damage in infertile sub-
jects also showed significant increase in sperm DNA
damage in infertile men over 40 y [41,53]. Moskovtsev
et al. reported doubling of sperm DNA fragmentation in
men ≥45 y compared to men <30 y [42]. This negative
impact of paternal age on sperm DNA damage can
occur earlier in infertile men, as reported in a study that
included 508 infertile men and showed a significant in-
crease in sperm DNA damage in men ≥35 y [43]. How-
ever, the risk increased significantly after the age of 40 y.
Another study included 61 infertile men with oligoasthe-
noteratozoospermia (OAT) that were divided into two
groups (≤34 y and ≥35 y). These investigators reported sig-
nificant increase in sperm DNA fragmentation in patients
who were ≥35 y compared to the younger group [25].
Several studies have shown a decline in fertility and re-
productive outcomes in men over 40y [55]. In a large
European multicenter study which included more than
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nificantly increased if the male partner of a woman aged
35-39 y was >40 y [33]. The same data also showed in-
crease in the risk of miscarriages in couples where the
woman was ≥35 y and the man was ≥40 y [10]. In an-
other retrospective study, Hellstrom et al. [56] tested
semen parameters in 1174 men aged 45 y and older to
derive the semen and sperm reference ranges by age
quartiles and compare to the established WHO 1999 ref-
erence values [57]. However, unlike our study group,
which was limited to age of the men seeking infertility
help, their study comprised of 4 groups of healthy sub-
jects (general population) without infertility problems.
Their age ranged from >45 y (group 1); >47.8 to 51.5 y
(group 2); >51.5 to 56.6 y (group 3) and >56.6 to 80.1 y
(group 4). In their study the mean age was 52.9 y, only
46% of the study subjects actually met or exceeded the
WHO reference values [57]. Their goal was to derive the
age matched reference values for semen parameters.
In addition they also stratified their population based
on age, smoking history, alcohol consumption or serum
hormone concentrations. One of our study limitations
was that it was a retrospective study. Another limitation
was that we did not examine the clinical diagnosis of
our infertile population and the patients were grouped
based only on the age. In addition, the data obtained in
the current study features a select population, i.e. that of
infertile men attending a tertiary care hospital. Another
reason for lack of significant differences in semen pa-
rameters may be because of the patient selection in dif-
ferent age groups. Ideally, investigation of the effect of
age on sperm quality and the relevant DNA damage
should be carried out using a non-selected population,
i.e. investigating different age groups enrolled inde-
pendently of any infertility problems. This approach
will allow the assessment of age as an independent risk
factor and allow for confirmation that semen parameters
worsen with age. However, this is a challenge as on-going
semen samples from healthy individuals are not easily
available.
The impact of advanced paternal age on ART out-
comes is still controversial [48]. Studies examining this
relationship are lacking, except the limited data supports
that paternal age >40 y is associated with failure to con-
ceive with IVF and ICSI. One such study is by De La
Rochebrochard et al. who investigated the effect of
paternal age on IVF outcomes. They examined 59 IVF
centers from France with a total of 1938 men whose
partners were totally sterile (bilateral tubal absence or
obstruction). The authors reported high risk of failure
to conceive after conventional IVF when the fathers
were >40 y [58]. The possible explanation for such nega-
tive influence of advanced paternal age on fertilization
and reproduction was the sperm DNA damage. An intactsperm DNA is essential for fertilization and for the gen-
etic transmission [23,36]. Sperm DNA fragmentation is
associated with several adverse outcomes including re-
duced fertility [37], increased miscarriage rates [38], ab-
normal embryonic development [39], and compromised
chromosomal integrity in the embryo [40]. Li and co-
workers reported in their meta-analysis that high degree
of sperm DNA damage, as assessed by TUNEL assay,
significantly reduces the chances of clinical pregnancy
through IVF, but not ICSI. However, sperm DNA dam-
age when assessed by SCSA showed no significant ef-
fects on clinical pregnancy rates after IVF and ICSI.
Furthermore, sperm DNA damage (assessed by TUNEL
assay) did not significantly affect fertilization rates in
IVF and ICSI [59].
In the present study, we found than men over 40 y are
at high risk of sperm DNA damage, and this may explain
the findings of previous reports which showed decline in
fertility, increased miscarriages, increased chromosomal
and genetic disorders, increased risk of low birth weight,
and decreased success of assisted reproduction. Duration
of infertility in our study was higher in men >40 y com-
pared to those ≤30 y.
Although the incidence of varicocele in the general
population is about 15%, majority of the infertility pa-
tients attending our male infertility clinic present with a
clinical varicocele. In our study, the overall incidence of
varicocele was 53.8% (253/470); and the distribution was
not very different in the 3 age groups i.e. 56.5% (39/69)
in <30 y; 38.9% (116/298) in 31 - 40 y and 46.6% (48/103)
in >40 y group. We did not examine other clinical causes
of male infertility besides the incidence of primary and sec-
ondary infertility or diagnosis of varicocele. We also stud-
ied the incidence of smoking and alcohol in these patients.
Finally, we did not find a significant association between
smoking, alcohol use or incidence and grade of varicocele
in men ≤40 y with those >40 y.
The clinical practice guideline of the Society of
Obstetricians and Gynecologists of Canada (SOGC) rec-
ommends to counsel partners about the potential risk of
seeking pregnancy when the male partner is over 40 y [60].
The American College of Obstetricians and Gynecologists
(ACOG) also recommends counseling the partners with
advanced male age (≥40 y) although they do not recom-
mend any screening tests but to treat the pregnant partner
as one would with any other pregnancy [29].
There is a general consensus that paternal ageing is
associated with decline in semen parameters and increas-
ing number of sperm with DNA damage. A recent review
highlights the effects of advanced paternal ageing on
semen parameters as well as IUI outcome [61,62]. In the
study by Beloc et al. sperm DNA fragmentation was re-
lated to poor motility in patients with select sperm defects
i.e. isolated oligozoospermia, isolated asthenozoospermia
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patients based on the age only, and it is likely that this
may have contributed to the significant overlap in the
values of semen parameters and lack of significant differ-
ences [63]. We did not examine the correlation of sperm
DNA damage with IVF outcome. It would be interesting
to see the correlation between sperm DNA fragmentation
and IVF outcome in the ART population; however it must
be noted that the population of our retrospective study
were infertile males presenting for semen analysis and not
ART candidates. Mitochondria are powerhouse organelle.
They play an important role in ATP synthesis, cell signal-
ing, reactive oxygen species by oxidative stress production
as well as apoptosis. The decline in germ cells, embryo de-
velopment as well as in implantation failure and miscar-
riage is related to mitochondrial–dependent apoptosis
[64,65]. The germ cell genome decay is the major cause of
male infertility and these findings emphasize the need for
molecular tools to examine the genetic and epigenetic
changes affected in male infertility.
Findings of our study imply the potential negative im-
pact of age on sperm DNA damage. We suggest that
couples should be counseled about the potential risks of
delayed parenthood when the female partner is >35 y
and the male partner is >40 y. Supplementation with
some exogenous antioxidants such as melatonin could
be considered to help reduce apoptosis and improve
DNA integrity in these patients [66-69].
In conclusion, advanced paternal age (>40 y) in infer-
tile men increases the risk of sperm DNA damage.
Evaluating sperm DNA damage in men of this age group
is important as it may compromise their fertilization
ability and increase the risk of poor ART outcome, and
several chromosomal and genetic disorders. Future stud-
ies are required to investigate the effects of compound-
ing factors such as varicocele, smoking or alcohol use on
the effect of ageing on sperm DNA damage.
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